Patents by Inventor Richard A. Morgan

Richard A. Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190388525
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Application
    Filed: July 3, 2019
    Publication date: December 26, 2019
    Applicant: bluebird bio, Inc.
    Inventors: Richard MORGAN, Kevin FRIEDMAN
  • Patent number: 10494412
    Abstract: The present invention relates to novel peptides, which impair PBX-dependent regulation of gene transcription and thus have utility in the treatment or prevention of disorders in which aberrant cell division occurs.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: December 3, 2019
    Assignee: HOX THERAPEUTICS LIMITED
    Inventor: Richard Morgan
  • Patent number: 10434241
    Abstract: A system for anal or stomal irrigation comprises a reservoir (102) for an irrigating liquid; a catheter (100) comprising a catheter tip for insertion into the rectum or stoma, a thermo sensor (128) connected to the reservoir for obtaining a measure of a temperature within the reservoir, a tubing system and/or the catheter. A control system (103) operatively connected with the thermo sensor is configured to determine a temperature within the reservoir. A method for predicting a temperature in a reservoir for irrigation liquid is also provided.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: October 8, 2019
    Assignee: Coloplast A/S
    Inventors: Niels Hvid, Richard Morgan Hickmott
  • Patent number: 10407485
    Abstract: The invention provides an isolated or purified T cell receptor (TCR) having antigenic specificity for NY-ESO-1. Also provided are related polypeptides, proteins, nucleic acids, recombinant expression vectors, isolated host cells, populations of cells, antibodies, or antigen binding portions thereof, and pharmaceutical compositions. The invention further provides a method of detecting the presence of cancer in a mammal and a method of treating or preventing cancer in a mammal using the inventive TCRs or related materials.
    Type: Grant
    Filed: August 29, 2018
    Date of Patent: September 10, 2019
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Maria R. Parkhurst, Richard A. Morgan, Steven A. Rosenberg, Shannon Faith Rosati
  • Publication number: 20190256502
    Abstract: The present invention relates to compounds of Formula I or a pharmaceutically salt or solvate thereof, which impair PBX-dependent transcription regulation, particularly which affect the binding of HOX to PBX and their use in a number of applications, including the reduction of aberrant cell division, e.g. to treat certain cancers, and to maintain pluripotency of stem cells, e.g. to maintain the pluripotency of stem cells during culture expansion. wherein R1, R2 and R3 are as defined herein.
    Type: Application
    Filed: September 15, 2017
    Publication date: August 22, 2019
    Applicant: HOX THERAPEUTICS LIMITED
    Inventor: Richard MORGAN
  • Patent number: 10383929
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: August 20, 2019
    Assignee: bluebird bio, Inc.
    Inventors: Richard Morgan, Kevin Friedman
  • Patent number: 10376637
    Abstract: The invention relates to an insertion device comprising —a penetrating member (50) connected to transformation means (52), —a moving part (38) comprising guiding means (39) which guiding means (39) restrict the movement of the transformation means (52) and guide the penetrating member (50) from a first to a second position in a first direction, i.e. the direction of insertion, towards the injection site, and —a stationary housing (30) comprising guiding means (32) which guiding means (32) restrict the movement of the moving part (38). The guiding means (32) guide the moving part (38) in a second direction which is linear and different from the first direction i.e. the direction of insertion.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: August 13, 2019
    Assignee: UNOMEDICAL A/S
    Inventors: Steffen Gyrn, Richard Morgan Hickmott, Alistair David Morton, Henrik Jeppesen
  • Patent number: 10369268
    Abstract: An anal irrigation system including a control unit (2) is provided. The control unit (2) is connected to an external tube (4) by an extension cord (9), so that pivoting of the control unit (2) with respect to the external tube (4) is possible.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: August 6, 2019
    Assignee: Coloplast A/S
    Inventors: Isak Frostaa, Hans Falleboe, Richard Morgan Hickmott, Niels Hvid
  • Patent number: 10372118
    Abstract: An energy monitoring system includes a memory storing instructions to execute an energy modeling technique and processing circuitry for executing the instructions to operate the energy modeling technique. The energy modeling technique includes receiving energy data from a plurality of segments representative of one or more logical subgroups. The energy modeling technique includes categorizing the energy data of the logical subgroups into a plurality of segments. The energy modeling technique includes organizing the plurality of segments into a plurality of state-based hierarchical levels. The energy modeling technique includes calculating energy usage and factors associated with the plurality of state-based hierarchical levels via an energy model. The energy modeling technique includes outputting a visualization representative of the energy data corresponding to each of the segments to a monitoring and control system, resulting in a graphical representation accessible by a user-viewable screen.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: August 6, 2019
    Assignee: Rockwell Automation Technologies, Inc.
    Inventors: Linglai Li, Guolin Zhang, David Brandt, Fred M. Discenzo, Philip Kaufman, David Berman, Phillip Bush, Sean C. Schmelzer, Steven Lombardi, Noel Henderson, Richard A. Morgan
  • Publication number: 20190230108
    Abstract: Embodiments presented herein describe techniques for generating a linguistic model of input data obtained from a data source (e.g., a video camera). According to one embodiment of the present disclosure, a sequence of symbols is generated based on an ordered stream of normalized vectors generated from the input data. A dictionary of words is generated from combinations of the ordered sequence of symbols based on a frequency at which combinations of symbols appear in the ordered sequence of symbols. A plurality of phrases is generated based an ordered sequence of words from the dictionary observed in the ordered sequence of symbols based on a frequency by which combinations of words in ordered sequence of words appear relative to one another.
    Type: Application
    Filed: December 11, 2018
    Publication date: July 25, 2019
    Applicant: Omni AI, Inc.
    Inventors: Ming-Jung SEOW, Wesley Kenneth COBB, Gang XU, Tao YANG, Aaron POFFENBERGER, Lon W. RISINGER, Kishor Adinath SAITWAL, Michael S. YANTOSCA, David M. SOLUM, Alex David HEMSATH, Dennis G. URECH, Duy Trong NGUYEN, Charles Richard MORGAN
  • Publication number: 20190124101
    Abstract: Embodiments presented herein describe a method for processing streams of data of one or more networked computer systems. According to one embodiment of the present disclosure, an ordered stream of normalized vectors corresponding to information security data obtained from one or more sensors monitoring a computer network is received. A neuro-linguistic model of the information security data is generated by clustering the ordered stream of vectors and assigning a letter to each cluster, outputting an ordered sequence of letters based on a mapping of the ordered stream of normalized vectors to the clusters, building a dictionary of words from of the ordered output of letters, outputting an ordered stream of words based on the ordered output of letters, and generating a plurality of phrases based on the ordered output of words.
    Type: Application
    Filed: May 13, 2018
    Publication date: April 25, 2019
    Inventors: Wesley Kenneth COBB, Ming-Jung SEOW, Curtis Edward COLE, Cody Shay FALCON, Benjamin A. KONOSKY, Charles Richard MORGAN, Aaron POFFENBERGER, Thong Toan NGUYEN
  • Publication number: 20190085092
    Abstract: The invention provides improved compositions for adoptive cell therapies for cancers that express the glycoepitope STn on TAG-72.
    Type: Application
    Filed: August 30, 2016
    Publication date: March 21, 2019
    Applicants: bluebird bio, Inc., ViroMed Co., LTD.
    Inventors: Richard MORGAN, Kevin FRIEDMAN, Seung Shin YU, Jae-Gyun JEONG, Jin-A CHAE
  • Publication number: 20190054143
    Abstract: The invention provides an isolated or purified T cell receptor (TCR) having antigenic specificity for synovial sarcoma X Breakpoint (SSX)-2. The invention further provides related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, and populations of cells. Further provided by the invention are antibodies, or an antigen binding portion thereof, and pharmaceutical compositions relating to the TCRs of the invention. Methods of detecting the presence of cancer in a host and methods of treating or preventing cancer in a host are further provided by the invention.
    Type: Application
    Filed: October 29, 2018
    Publication date: February 21, 2019
    Applicant: The United States of America,as represented by the Secretary,Department of Health and Human Services
    Inventors: Richard A. Morgan, Dhanalakshmi Dhanalakshmi, Steven A. Rosenberg
  • Patent number: 10187415
    Abstract: Embodiments presented herein describe techniques for generating a linguistic model of input data obtained from a data source (e.g., a video camera). According to one embodiment of the present disclosure, a sequence of symbols is generated based on an ordered stream of normalized vectors generated from the input data. A dictionary of words is generated from combinations of the ordered sequence of symbols based on a frequency at which combinations of symbols appear in the ordered sequence of symbols. A plurality of phrases is generated based an ordered sequence of words from the dictionary observed in the ordered sequence of symbols based on a frequency by which combinations of words in ordered sequence of words appear relative to one another.
    Type: Grant
    Filed: March 26, 2017
    Date of Patent: January 22, 2019
    Assignee: Omni AI, Inc.
    Inventors: Ming-Jung Seow, Wesley Kenneth Cobb, Gang Xu, Tao Yang, Aaron Poffenberger, Lon W. Risinger, Kishor Adinath Saitwal, Michael S. Yantosca, David M. Solum, Alex David Hemsath, Dennis G. Urech, Duy Trong Nguyen, Charles Richard Morgan
  • Publication number: 20190016777
    Abstract: The invention provides an isolated or purified T cell receptor (TCR) having antigenic specificity for a) melanoma antigen family A (MAGE A)-3 in the context of HLA-A1 or b) MAGE-A12 in the context of HLA-Cw7. The invention further provides related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, and populations of cells. Further provided by the invention are antibodies, or an antigen binding portion thereof, and pharmaceutical compositions relating to the TCRs of the invention. Methods of detecting the presence of cancer in a host and methods of treating or preventing cancer in a host are further provided by the invention.
    Type: Application
    Filed: September 27, 2018
    Publication date: January 17, 2019
    Applicant: The United States of America,as represented by the Secretary,Department of Health and Human Services
    Inventors: Paul F. Robbins, Steven A. Rosenberg, Shiqui Zhu, Steven A. Feldman, Richard A. Morgan
  • Publication number: 20180371050
    Abstract: The invention provides an isolated or purified T cell receptor (TCR) having antigenic specificity for NY-ESO-1. Also provided are related polypeptides, proteins, nucleic acids, recombinant expression vectors, isolated host cells, populations of cells, antibodies, or antigen binding portions thereof, and pharmaceutical compositions. The invention further provides a method of detecting the presence of cancer in a mammal and a method of treating or preventing cancer in a mammal using the inventive TCRs or related materials.
    Type: Application
    Filed: August 29, 2018
    Publication date: December 27, 2018
    Applicant: The United States of America,as represented by the Secretary,Department of Health and Human Services
    Inventors: Maria R. Parkhurst, Richard A. Morgan, Steven A. Rosenberg, Shannon Faith Rosati
  • Patent number: 10143724
    Abstract: The invention provides an isolated or purified T cell receptor (TCR) having antigenic specificity for synovial sarcoma X Breakpoint (SSX)-2. The invention further provides related polypeptides and proteins, as well as related nucleic acids, recombinant expression vectors, host cells, and populations of cells. Further provided by the invention are antibodies, or an antigen binding portion thereof, and pharmaceutical compositions relating to the TCRs of the invention. Methods of detecting the presence of cancer in a host and methods of treating or preventing cancer in a host are further provided by the invention.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: December 4, 2018
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Richard A. Morgan, Nachimuthu Chinnasamy, Steven A. Rosenberg
  • Publication number: 20180282384
    Abstract: The present invention relates to novel peptides, which impair PBX-dependent regulation of gene transcription and thus have utility in the treatment or prevention of disorders in which aberrant cell division occurs.
    Type: Application
    Filed: October 20, 2016
    Publication date: October 4, 2018
    Applicant: HOX THERAPEUTICS LIMITED
    Inventor: Richard MORGAN
  • Patent number: 10087230
    Abstract: The invention provides an isolated or purified T cell receptor (TCR) having antigenic specificity for NY-ESO-1. Also provided are related polypeptides, proteins, nucleic acids, recombinant expression vectors, isolated host cells, populations of cells, antibodies, or antigen binding portions thereof, and pharmaceutical compositions. The invention further provides a method of detecting the presence of cancer in a mammal and a method of treating or preventing cancer in a mammal using the inventive TCRs or related materials.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: October 2, 2018
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Maria R. Parkhurst, Richard A. Morgan, Steven A. Rosenberg, Shannon Faith Rosati
  • Publication number: 20180169377
    Abstract: A urinary catheter assembly having a sleeve is provided. The urinary catheter assembly comprises a urinary catheter (2) having a hydrophilic surface; the urinary catheter being provided with an insertion tip (5) in a proximal insertion end of the urinary catheter and an outlet (4) at a distal end of the urinary catheter, a handle (8) being slidingly disposed on the urinary catheter, a collapsible, flexible sleeve (7) attached to the handle and being configured to cover the urinary catheter from the outlet to the tip portion in an extended configuration of the urinary catheter assembly, the sleeve being attached to a connector (9) at the outlet, the connector and handle configured to be detachably attached to each other and define a cavity provided by the sleeve, handle and connector encapsulating an entirety of the urinary catheter in a storage condition.
    Type: Application
    Filed: June 24, 2016
    Publication date: June 21, 2018
    Applicant: Coloplast A/S
    Inventors: Richard Morgan Hickmott, Martin Wraber, Marie Bay Borg